Published in Respir Res on August 09, 2011
Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities. Antioxid Redox Signal (2012) 0.97
Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses (2012) 0.91
Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. Am J Respir Cell Mol Biol (2014) 0.90
Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J Pathol (2015) 0.89
Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection. Antiviral Res (2015) 0.83
MMP-12-mediated by SARM-TRIF signaling pathway contributes to IFN-γ-independent airway inflammation and AHR post RSV infection in nude mice. Respir Res (2015) 0.81
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection. BMC Res Notes (2014) 0.80
Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments. ILAR J (2014) 0.80
Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells. Viruses (2013) 0.80
A Preliminary Assessment of the Role of Ambient Nitric Oxide Exposure in Hospitalization with Respiratory Syncytial Virus Bronchiolitis. Int J Environ Res Public Health (2016) 0.76
Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus. Biomed Res Int (2015) 0.76
Immune exhaustion during chronic infections in cattle. J Vet Med Sci (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2005) 28.04
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature (2006) 20.00
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med (2006) 13.15
Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol (1969) 10.85
Innate immunity: the virtues of a nonclonal system of recognition. Cell (1997) 9.42
The many faces of macrophage activation. J Leukoc Biol (2003) 8.95
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med (2006) 8.18
Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol (1968) 7.67
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J Infect Dis (2007) 3.62
The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol (2006) 2.43
Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child (1994) 2.13
Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med (2002) 2.12
Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr Res (1976) 1.99
Neutrophil production and function in newborn infants. Br J Haematol (2000) 1.88
Respiratory syncytial virus load predicts disease severity in previously healthy infants. J Infect Dis (2005) 1.74
Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics (1991) 1.54
Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics (1975) 1.45
Defective bactericidal activity in myeloperoxidase-deficient human neutrophils. Nature (1969) 1.29
Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J Virol (2006) 1.28
Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect (2004) 1.27
CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J Immunol (2007) 1.26
Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics. Pharmacol Ther (2006) 1.10
Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J Paediatr Child Health (2001) 1.09
RSV-induced immunopathology: dynamic interplay between the virus and host immune response. Virology (2002) 1.06
The 'PREXCEL-Q Method' for qPCR. Int J Biomed Sci (2008) 1.06
Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis. Am J Dis Child (1989) 1.04
Experimentally induced respiratory syncytial viral infection in lambs. Am J Vet Res (1979) 1.02
Hereditary myeloperoxidase deficiency. Blood (1981) 1.01
The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine (2010) 1.01
Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. Dev Comp Immunol (2009) 1.00
Innate immune responses in respiratory syncytial virus infections. Viral Immunol (2004) 1.00
Respiratory syncytial virus-induced immunoprotection and immunopathology. Viral Immunol (2004) 0.99
Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol (2010) 0.95
Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis. Adv Ther (2011) 0.95
Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. Clin Exp Immunol (2004) 0.94
Respiratory syncytial virus and T cells: interplay between the virus and the host adaptive immune system. Proc Am Thorac Soc (2005) 0.93
Birth weight and hospital readmission of infants born prematurely. Arch Pediatr Adolesc Med (1994) 0.93
Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention. Adv Ther (2011) 0.90
Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung. J Histochem Cytochem (2006) 0.84
Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine (2001) 0.84
Experimental respiratory syncytial virus infection in feeder-age lambs. Am J Vet Res (1979) 0.83
Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age. Eur J Clin Microbiol Infect Dis (2008) 0.83
Lesions in lambs experimentally infected with bovine respiratory syncytial virus. Am J Vet Res (1979) 0.83
Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine (2006) 2.37
Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem (2006) 1.79
Electrogram characteristics in postinfarction ventricular tachycardia: effect of infarct age. J Am Coll Cardiol (2005) 1.60
The need for transparency and good practices in the qPCR literature. Nat Methods (2013) 1.58
Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun (2002) 1.54
Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care (2014) 1.48
Accuracy of electrocardiogram interpretation by cardiologists in the setting of incorrect computer analysis. J Electrocardiol (2006) 1.44
Reduced clearance of respiratory syncytial virus infection in a preterm lamb model. Microbes Infect (2004) 1.27
Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs. Clin Diagn Lab Immunol (2004) 1.25
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood (2003) 1.14
Infection and propagation of human rhinovirus C in human airway epithelial cells. J Virol (2012) 1.14
Differential expression of ovine innate immune genes by preterm and neonatal lung epithelia infected with respiratory syncytial virus. Viral Immunol (2006) 1.11
Addressing fluorogenic real-time qPCR inhibition using the novel custom Excel file system 'FocusField2-6GallupqPCRSet-upTool-001' to attain consistently high fidelity qPCR reactions. Biol Proced Online (2006) 1.10
New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR. Biol Proced Online (2005) 1.08
The 'PREXCEL-Q Method' for qPCR. Int J Biomed Sci (2008) 1.06
Development of an in vivo RNAi protocol to investigate gene function in the filarial nematode, Brugia malayi. PLoS Pathog (2010) 1.03
Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. J Infect Dis (2011) 1.03
Immunologic indicators of clinical progression during canine Leishmania infantum infection. Clin Vaccine Immunol (2009) 1.02
Maternal alcohol ingestion reduces surfactant protein A expression by preterm fetal lung epithelia. Alcohol (2007) 1.02
Gene profiling studies in the neonatal ovine lung show enhancing effects of VEGF on the immune response. Dev Comp Immunol (2009) 1.00
Bachmann Bundle and its arterial supply: imaging with multidetector CT--implications for interatrial conduction abnormalities and arrhythmias. Radiology (2008) 0.99
Coordinated expression of tracheal antimicrobial peptide and inflammatory-response elements in the lungs of neonatal calves with acute bacterial pneumonia. Infect Immun (2003) 0.99
Expression of select immune genes (surfactant proteins A and D, sheep beta defensin 1, and toll-like receptor 4) by respiratory epithelia is developmentally regulated in the preterm neonatal lamb. Dev Comp Immunol (2006) 0.97
Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children. Pediatr Infect Dis J (2009) 0.95
Respiratory syncytial virus is associated with an inflammatory response in lungs and architectural remodeling of lung-draining lymph nodes of newborn lambs. Am J Physiol Lung Cell Mol Physiol (2010) 0.95
Differential expression of sheep beta-defensin-1 and -2 and interleukin 8 during acute Mannheimia haemolytica pneumonia. Microb Pathog (2004) 0.95
CD8+ T cells in HIV disease exhibit cytokine receptor perturbation and poor T cell receptor activation but are responsive to gamma-chain cytokine-driven proliferation. J Infect Dis (2006) 0.94
Developmental expression and distribution of sheep beta-defensin-2. Dev Comp Immunol (2004) 0.94
Surfactant protein D expression in normal and pneumonic ovine lung. Vet Immunol Immunopathol (2004) 0.93
Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res (2011) 0.92
Adenovirus-mediated gene therapy enhances parainfluenza virus 3 infection in neonatal lambs. J Clin Microbiol (2004) 0.92
Right atrial cavotricuspid isthmus: anatomic characterization with multi-detector row CT. Radiology (2008) 0.91
Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses (2012) 0.91
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells. Leuk Res (2008) 0.90
Increased concentration of iodide in airway secretions is associated with reduced respiratory syncytial virus disease severity. Am J Respir Cell Mol Biol (2014) 0.90
Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comp Med (2009) 0.89
Detection of phrenic nerves and their relation to cardiac anatomy using 64-slice multidetector computed tomography. Am J Cardiol (2007) 0.88
Pretreatment with recombinant human vascular endothelial growth factor reduces virus replication and inflammation in a perinatal lamb model of respiratory syncytial virus infection. Viral Immunol (2007) 0.88
Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus. J Gen Virol (2008) 0.87
Pulmonary cyclooxygenase-1 (COX-1) and COX-2 cellular expression and distribution after respiratory syncytial virus and parainfluenza virus infection. Viral Immunol (2010) 0.86
Neonatal ovine pulmonary dendritic cells support bovine respiratory syncytial virus replication with enhanced interleukin (IL)-4 And IL-10 gene transcripts. Viral Immunol (2007) 0.86
Genomic features of Bordetella parapertussis clades with distinct host species specificity. Genome Biol (2006) 0.86
Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antiviral Res (2010) 0.85
Laser Capture Microdissection Revisited as a Tool for Transcriptomic Analysis: Application of an Excel-Based qPCR Preparation Software (PREXCEL-Q). Int J Biomed Sci (2009) 0.85
Depletion of alveolar glycogen corresponds with immunohistochemical development of CD208 antigen expression in perinatal lamb lung. J Histochem Cytochem (2006) 0.84
Repeated intravenous doses of all-trans-retinoyl beta-D-glucuronide is not effective in the treatment of bacterial bronchopneumonia in lambs but is devoid of gross and acute toxicity. Med Sci Monit (2002) 0.84
The genetic immunodeficiency disease, leukocyte adhesion deficiency, in humans, dogs, cattle, and mice. Comp Med (2004) 0.84
Differential expression of cytokine transcripts in neonatal and adult ovine alveolar macrophages in response to respiratory syncytial virus or toll-like receptor ligation. Vet Immunol Immunopathol (2010) 0.84
Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease. Am J Vet Res (2012) 0.83
Exposure to ethanol during the last trimester of pregnancy alters the maturation and immunity of the fetal lung. Alcohol (2010) 0.83
Cardiac conduction system: anatomic landmarks relevant to interventional electrophysiologic techniques demonstrated with 64-detector CT. Radiographics (2007) 0.83
Mechanisms of ventricular arrhythmias in heart failure. Curr Heart Fail Rep (2005) 0.83
Antimicrobial peptides and surfactant proteins in ruminant respiratory tract disease. Vet Immunol Immunopathol (2005) 0.83
Roadblocks to translational challenges on viral pathogenesis. Nat Med (2013) 0.82
Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV. PLoS One (2013) 0.81
Effects of nicotine on pulmonary surfactant proteins A and D in ovine lung epithelia. Pediatr Pulmonol (2010) 0.80
Lamb model of respiratory syncytial virus-associated lung disease: insights to pathogenesis and novel treatments. ILAR J (2014) 0.80
Ontogeny of the immune response in the ovine lung. Immunol Invest (2011) 0.80
Sucrose stabilization of Respiratory Syncytial Virus (RSV) during nebulization and experimental infection. BMC Res Notes (2014) 0.80
Human respiratory syncytial virus Memphis 37 grown in HEp-2 cells causes more severe disease in lambs than virus grown in Vero cells. Viruses (2013) 0.80
Increased anionic peptide distribution and intensity during progression and resolution of bacterial pneumonia. Clin Diagn Lab Immunol (2002) 0.79
Gene expression in intestinal mucosal biopsy specimens obtained from dogs with chronic enteropathy. Am J Vet Res (2012) 0.77
RAGE inhibits human respiratory syncytial virus syncytium formation by interfering with F-protein function. J Gen Virol (2013) 0.77
Ontogeny of pulmonary cyclooxygenase-1 (COX-1) and -2 (COX-2). Pathophysiology (2011) 0.76
Posterior interatrial muscular connection between the coronary sinus and left atrium: anatomic and functional study of the coronary sinus with multidetector CT. Radiology (2011) 0.76
Distribution of substance P receptor (neurokinin-1 receptor) in normal ovine lung and during the progression of bronchopneumonia in sheep. J Histochem Cytochem (2004) 0.75
Successful medical treatment of an orbital osteoma in a dog. Vet Ophthalmol (2012) 0.75